Patient-derived organoids as a reliable screening platform for assessing ADC efficacy and specificity

April 29, 2024

Patient-derived organoids as a reliable screening platform for assessing ADC efficacy and specificity

read more

Resistant PDO models: Unraveling drug resistance mechanisms for discovering new drug targets

April 29, 2024

Resistant PDO models: Unraveling drug resistance mechanisms for discovering new drug targets

read more

Patient-derived organoids: A pre-clinical model to assess infection and killing capacity of viral vectors for cancer therapy

April 29, 2024

Patient-derived organoids: A pre-clinical model to assess infection and killing capacity of viral vectors for cancer therapy

read more

Miniaturizing patient-derived organoid screening assays for predictive drug testing

April 29, 2024

Miniaturizing patient-derived organoid screening assays for predictive drug testing

read more

Tumor organoid and immune cells co-cultures to study myeloid cells-targeting immunotherapy

April 29, 2024

Tumor organoid and immune cells co-cultures to study myeloid cells-targeting immunotherapy

read more

Mechanistic validation of MAIT cell engagers in HUB Patient-Derived Organoids (PDO) co-culture model

April 29, 2024

Mechanistic validation of MAIT cell engagers in HUB Patient-Derived Organoids (PDO) co-culture model

read more

A patient-derived organoid platform to assess the effectiveness of γδTCR cell therapy in solid tumors

April 29, 2024

A patient-derived organoid platform to assess the effectiveness of γδTCR cell therapy in solid tumors

read more

HUB Organoids as a Reliable Platform to Assess Gastrointestinal Toxicity

March 20, 2024

HUB Organoids as a Reliable Platform to Assess Gastrointestinal Toxicity

read more

Enhancing Drug Safety and ADME Assessment with Organoids

March 19, 2024

Enhancing Drug Safety and ADME Assessment with Organoids

read more

Patient-derived Organoids: a powerful preclinical platform for de-risking immuno-oncology therapies

March 12, 2024

Patient-derived Organoids: a powerful preclinical platform for de-risking immuno-oncology therapies

read more

X

Have any questions?

contact us